Consumers often lack targeted, easy-to-use products for supporting the gut microbiome across digestion, immunity, metabolism and other health goals.
R&D Focus
Evidence-based probiotic, prebiotic, postbiotic and synbiotic supplements.
Innovative Solution
Medical, pharmaceutical and nutrition specialists develop goal-specific microbiome supplements, including gut capsules, fiber drinks, protein products and women’s-health formulations.
Solution Effectiveness
The German store displayed a Trustpilot score of 4.6 out of 5.
Investment Funding
Last Funding Stage
Series A
Total Funding Amount
7.67M
Last Funding Amount
5.93M
Last Funding Date
19-10-2023
Startup Stage
Early Stage
Lead Investors
naturalX Health Ventures, Global Founders Capital, Joyance Partners, WENVEST Capital, Social Starts
Revenue
$1M to $10M
People
Founders
Carl-Philipp von Polheim
Sebastian Wahl
About
mybacs is a research-driven DTC company specialized in the human microbiome. Our goal is to revolutionize the market around intestinal healthcare and thus make a decisive contribution to the daily well-being of our customers. Our team of pharmaceutical scientists and physicians is focused on the development of innovative and highly-dosed synbiotic supplements. These are aligned by our singular formulations from specifically selected probiotic cultures, prebiotics as well as minerals and vitamins tailored to the individual needs of our customers.
Products
Product
Gut-health capsules, fiber drinks, weight-management and protein shakes, collagen and multivitamin drinks, children’s products and women’s-health supplements.
Demo Product or Complete Product?
Complete products are commercially available.
Future Plan
Market Expansion
The company operates localized stores beyond Germany, including a Spanish-language market site.
Investment Funding
Closed a Seed II round in 2020 and a Series A round in 2023; CB Insights reports the Series A at about $5.92 million.
Awards and Recognitions
Certifications
Company website states products are allergen-free, lactose-free, scientifically reviewed and developed in Switzerland.
Something missing or incorrect on this page? Help us enrich this information
